Portal:CPTAC/Hallmark/Proliferative
From WikiPathways
(Difference between revisions)
(test) |
(removed test) |
||
Line 1: | Line 1: | ||
- | |||
*[[Pathway:WP3972]] PDGFR-beta pathway | *[[Pathway:WP3972]] PDGFR-beta pathway | ||
*[[Pathway:WP673]] ErbB Signaling Pathway | *[[Pathway:WP673]] ErbB Signaling Pathway |
Revision as of 21:03, 8 November 2018
- Pathway:WP3972 PDGFR-beta pathway
- Pathway:WP673 ErbB Signaling Pathway
- Pathway:WP581 EPO Receptor Signaling
- Pathway:WP382 MAPK Signaling Pathway
- Pathway:WP4223 Ras Signaling
- Pathway:WP2828 Bladder Cancer
- Pathway:WP4205 MET in type 1 papillary renal cell carcinoma
- Pathway:WP4255 Non-small cell lung cancer
- Pathway:WP4263 Pancreatic adenocarcinoma pathway
- Pathway:WP4155 Endometrial cancer